K A Eghiazaryan, I G Chulovskaya, A M Shatov, V S Kosmynin, D S Zharov
{"title":"[The modern concept of anesthesiological provision of surgical interventions in geriatric patients with diseases of the hand and forearm].","authors":"K A Eghiazaryan, I G Chulovskaya, A M Shatov, V S Kosmynin, D S Zharov","doi":"10.17116/hirurgia202410188","DOIUrl":null,"url":null,"abstract":"<p><p>The article analyzes literature data on the characteristics of local anesthetics used to perform regional anesthesia, and provides a detailed assessment of the drug \"Articaine\". The article presents the results of an open randomized study of the action of the anesthetics \"Articaine-Binergia\" 20 mg/ml and \"Ropivocaine\" used to perform conduction anesthesia in upper limb surgeries. The results of the study demonstrated a high degree of effectiveness of both drugs, but the safety indicators of the drug \"Articaine-Binergia\" 20 mg/ml significantly exceeded those of \"Ropivocaine\". The studies have established that the drug \"Articaine-Binergia\" 20 mg/ml is characterized by a short latent period, which allows for optimization of the operating room. At the same time, the peculiarity of \"Ropivocaine\" was the duration of action, which ensures the possibility of performing long surgical interventions, and maintaining the analgesic effect in the first hours after surgery. The results of the studies allowed us to recommend Articaine-Binergia 20 mg/ml as an effective local analgesic with a high degree of safety for widespread practical use in upper limb surgeries. The use of Ropivacaine for conduction anesthesia should be limited to surgical interventions that last longer than the duration of action of Articaine-Binergia 20 mg/ml, which is 2 hours 20 minutes. In addition, highly traumatic surgical interventions in patients with absolute contraindications to the use of painkillers are a limitation.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 10","pages":"88-96"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Khirurgiya","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17116/hirurgia202410188","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
The article analyzes literature data on the characteristics of local anesthetics used to perform regional anesthesia, and provides a detailed assessment of the drug "Articaine". The article presents the results of an open randomized study of the action of the anesthetics "Articaine-Binergia" 20 mg/ml and "Ropivocaine" used to perform conduction anesthesia in upper limb surgeries. The results of the study demonstrated a high degree of effectiveness of both drugs, but the safety indicators of the drug "Articaine-Binergia" 20 mg/ml significantly exceeded those of "Ropivocaine". The studies have established that the drug "Articaine-Binergia" 20 mg/ml is characterized by a short latent period, which allows for optimization of the operating room. At the same time, the peculiarity of "Ropivocaine" was the duration of action, which ensures the possibility of performing long surgical interventions, and maintaining the analgesic effect in the first hours after surgery. The results of the studies allowed us to recommend Articaine-Binergia 20 mg/ml as an effective local analgesic with a high degree of safety for widespread practical use in upper limb surgeries. The use of Ropivacaine for conduction anesthesia should be limited to surgical interventions that last longer than the duration of action of Articaine-Binergia 20 mg/ml, which is 2 hours 20 minutes. In addition, highly traumatic surgical interventions in patients with absolute contraindications to the use of painkillers are a limitation.